These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 35260044)
1. Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis. Zhang Y; Yu Y; Cao X; Chen P Bioengineered; 2022 Mar; 13(3):6476-6489. PubMed ID: 35260044 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653 [TBL] [Abstract][Full Text] [Related]
4. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis. Wang A; Wang J DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763 [TBL] [Abstract][Full Text] [Related]
5. FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells. Zhao W; Guo J; Li H; Cai L; Duan Y; Hou X; Diao Z; Shao X; Du H; Li C BMC Cancer; 2021 Dec; 21(1):1310. PubMed ID: 34876040 [TBL] [Abstract][Full Text] [Related]
6. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis. Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway. Ma YK; Shen TH; Yang XY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410 [TBL] [Abstract][Full Text] [Related]
9. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression. Li J; Li Y; Sun X; Wei L; Guan J; Fu L; Du J; Zhang X; Cheng M; Ma H; Jiang S; Zheng Q; Wang L Mol Carcinog; 2024 Apr; 63(4):757-771. PubMed ID: 38289172 [TBL] [Abstract][Full Text] [Related]
10. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis. Duan H; Li X; Chen Y; Wang Y; Li Z Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429 [TBL] [Abstract][Full Text] [Related]
11. The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway. Wang Z; Liu L; Du Y; Mi Y; Wang L Cell Biol Toxicol; 2021 Oct; 37(5):715-729. PubMed ID: 33755848 [TBL] [Abstract][Full Text] [Related]
12. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis. Lu YH; He DS; Li Y; Wang H; Ma RD Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung Adenocarcinoma. Xue Y; Diao M; Lyu J; Li K; He L; Chen J; Li X Cancer Biother Radiopharm; 2024 Oct; 39(8):573-583. PubMed ID: 34767727 [No Abstract] [Full Text] [Related]
15. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p. Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289 [TBL] [Abstract][Full Text] [Related]
16. LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p. Wang Y; Zou Y; Zhang Q; Chen D; Lin L J Healthc Eng; 2022; 2022():2223149. PubMed ID: 35444785 [TBL] [Abstract][Full Text] [Related]
17. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer. Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460 [TBL] [Abstract][Full Text] [Related]
18. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372 [TBL] [Abstract][Full Text] [Related]
19. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related]
20. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]